(Q39787486)

14 September 2017

title

The balance of autocrine VEGF-A and VEGF-C determines podocyte survival (English)

1 reference

14 September 2017

6

1 reference

14 September 2017

3

Moin Saleem

1 reference

14 September 2017

5

Hermann Haller

1 reference

14 September 2017

4

Irini Tossidou

1 reference

14 September 2017

2

Kirstin Worthmann

1 reference

14 September 2017

Janina Müller-Deile

1

1 reference

14 September 2017

language of work or name

1 reference

14 October 2009

1 reference

American Journal of Physiology - Renal Physiology

14 September 2017

published in

1 reference

14 September 2017

volume

297

1 reference

14 September 2017

issue

6

1 reference

14 September 2017

page(s)

F1656-67

1 reference

Decreased renal expression of vascular endothelial growth factor in lupus nephritis is associated with worse prognosis.

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00275.2009

Vascular endothelial growth factor increases hydraulic conductivity of isolated perfused microvessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00275.2009

Differentiated human podocytes endogenously express an inhibitory isoform of vascular endothelial growth factor (VEGF165b) mRNA and protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00275.2009

Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00275.2009

VEGF inhibition and renal thrombotic microangiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00275.2009

Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00275.2009

VEGF-C promotes survival in podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00275.2009

Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00275.2009

Vascular endothelial growth factor and nephrin interact and reduce apoptosis in human podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00275.2009

Urinary podocyte excretion as a marker for preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00275.2009

Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00275.2009

Autocrine VEGF-A system in podocytes regulates podocin and its interaction with CD2AP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00275.2009

Renal effects of anti-angiogenesis therapy: update for the internist

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00275.2009

The slit diaphragm: a signaling platform to regulate podocyte function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00275.2009

Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00275.2009

Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00275.2009

A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00275.2009

Profile and Molecular Modeling of 3-(Indole-3-yl)-4-(3,4,5-trimethoxyphenyl)-1H-pyrrole-2,5dione (1) as a Highly Selective VEGF-R2/3 Inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00275.2009

Apoptosis in podocytes induced by TGF-beta and Smad7

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00275.2009

Erythropoietin prevents diabetes-induced podocyte damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00275.2009

A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00275.2009

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00275.2009

The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00275.2009

Vascular endothelial growth factor: a new member of the platelet-derived growth factor gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00275.2009

CD2AP/CIN85 balance determines receptor tyrosine kinase signaling response in podocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00275.2009

Expression of placenta growth factor is regulated by both VEGF and hyperglycaemia via VEGFR-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00275.2009

10.1152/AJPRENAL.00275.2009

21 January 2018

Identifiers

DOI

1 reference

release_4anfjyo6yzefdcu5sqadzjh6hm

14 September 2017

Fatcat ID

0 references

1 reference